Stay updated on Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-04T00:53:03.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    A sitewide notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” across NIH content. The site revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:55:19.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The site's footer revision identifier changes from v3.7.0 to v3.7.1 on an otherwise unchanged 403 error page.
    Difference
    0.2%
    Check dated 2026-10-07T01:11:08.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of its content, indicating an access restriction that blocks viewing the study record and navigation.
    Difference
    18%
    Check dated 2026-09-23T01:08:03.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.6 (removed) to v3.7.0 (added), indicating an update to the page's revision history/template rather than any changes to study details.
    Difference
    0.0%
    Check dated 2026-09-16T00:27:10.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing Revision: v3.6.5. This reflects a small internal update to the site without changing the study details or user-facing functionality.
    Difference
    0.0%
    Check dated 2026-09-01T20:33:22.000Z thumbnail image

Stay in the know with updates to Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page.